TIDES Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
TIDES Europe 2026 Exhibitors
Nov 3–5, 2026 Amsterdam, Netherlands ~900 attendees Website
99 organizations exhibit at TIDES Europe 2026 — 97 suppliers and service providers and 2 drug developers. 27 of them also present on the scientific program, with 40 presentations between them. Most represented: Bachem (5 on the program), PolyPeptide Group (4 on the program), Codexis (3 on the program). 99 of them have their own page in this guide. As of Nov 2, 2026.
Focus
Top represented
Showing 1–30 of 99 organizations
| Organization | TIDES Europe 2026 Attendance |
|---|---|
Bachem Bubendorf, Switzerland | |
Contract development and manufacturing organization for peptide and oligonucleotide active pharmaceutical ingredients, from research quantities to commercial scale. | Booth Exhibiting at Booth 703 Tue, Nov 33:00pm–6:30pmWed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Wed Nov 4 14:30–15:00 Beyond Packed Beds: Advancing Scalable Oligonucleotide Manufacturing Through Stirred-Bed Technology Building oligonucleotides in a continuously stirred reactor rather than a packed column, so reagents mix evenly and batches can reach ton scale. Talk Wed Nov 4 16:15–16:45 Dapiglutide: From Lab to Large Scale Manufacture through Innovative Peptide Process Development How process changes in making the peptide drug dapiglutide raised its overall yield from about 20% to over 60%. Talk Wed Nov 4 15:00–15:30 Dehydroascorbate: More Sustainable Disulfide Bond Formation in Peptide Manufacturing Using an oxidised form of vitamin C instead of harsh chemicals to form the sulfur bridges that hold many peptide drugs in shape. Talk Wed Nov 4 11:50–12:20 Digital Manufacturing in Practice: Enabling Efficient and Compliant Large-scale Production Running large-scale production on digital records and automation, and what that changed for output, consistency and the ability to spot process problems. CMC & Manufacturing Chair Thu Nov 5 08:00–08:05 |
PolyPeptide Group Baar, Switzerland | |
Contract development and manufacturing organization for peptide and oligonucleotide APIs, from clinical to commercial scale. | Booth Exhibiting at Booth 309 Tue, Nov 33:00pm–6:30pmWed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Tue Nov 3 09:05–09:35 Strategies for Manufacturing of Long and Complex Peptides: Technical Considerations and Case Studies Ways to make long, sticky peptides at scale by mixing solid-support and solution methods and cutting solvent use, with real examples. Talk Wed Nov 4 14:00–14:30 Case Studies of Pre-clinical Development and IND Acceleration for Peptides Case studies on lining up early peptide process work, manufacturing plans and safety testing so a drug reaches first clinical trials sooner. |
Codexis Redwood City, CA | |
Engineers enzymes and the ECO Synthesis enzymatic platform for manufacturing siRNA and other RNA therapeutics. | Booth Exhibiting at Booth 508 Tue, Nov 33:00pm–6:30pmWed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Wed Nov 4 15:00–15:30 Advancing siRNA Manufacturing at Scale and with User-Defined Phosphorothioate Stereochemistry How an enzyme-based process controls the mirror-image shape of sulfur-containing backbone links in siRNA, now made at the 100-gram scale. Talk Wed Nov 4 09:45–09:55 Delivering Scalable siRNA Therapeutics Sustainably How an enzyme-based way of making siRNA drugs is scaling up, recently reaching 100 grams, while using less solvent. OligonucleotidesCMC & Manufacturing |
Axolabs Kulmbach, Germany | |
Oligonucleotide contract research and manufacturing organization offering discovery, preclinical, analytical and GMP manufacturing services. | Booth Exhibiting at Booth 515 Tue, Nov 33:00pm–6:30pmWed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Tue Nov 3 09:05–09:45 Chair Tue Nov 3 09:00–09:05 Workshop Moderators’ Introduction Which early manufacturing and quality decisions set what an oligonucleotide drug costs to produce, and when in development they should be taken. Talk Wed Nov 4 13:25–13:55 From Development Candidate Nomination to First-in-Human: Accelerating Oligonucleotide Development Through Integrated Strategies What it took to move a sugar-tagged siRNA candidate from selection to its first human trial on a tight schedule. OligonucleotidesCMC & Manufacturing |
Agilent Technologies Santa Clara, CA | |
Makes liquid chromatography, mass spectrometry and other analytical instruments, and manufactures oligonucleotide active pharmaceutical ingredients under contract. | Booth Exhibiting at Booth 409 Tue, Nov 33:00pm–6:30pmWed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Wed Nov 4 16:45–17:15 Analytical Method Validation Across the Oligonucleotide Lifecycle How a contract manufacturer validates the tests used to check oligonucleotide drugs, from raw materials to release, without slowing development. Talk Wed Nov 4 11:50–12:20 Integrated Analytical Workflows for Synthetic Peptide Development: From Peptide Separation to Sequence Confirmation Combining separation, mass measurement and software to confirm a synthetic peptide's sequence, purity and starting materials at every stage. PeptidesCMC & Manufacturing |
Almac Craigavon, United Kingdom | |
Drug development services for small molecules and peptides, including analytical testing, API supply, radiolabelling, formulation and solid-state services. | Booth Exhibiting at Booth 620 Tue, Nov 33:00pm–6:30pmWed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Tue Nov 3 11:00–11:30 Individualised Cancer Vaccines: Developing a High-throughput cGMP Peptide Manufacturing Philosophy How to make twenty different peptides to clinical quality in twenty days for one patient's personalised cancer vaccine, then do it again. Talk Thu Nov 5 10:45–11:25 Part 1: siRELIS: A Convergent Enzymatic Ligation Strategy for siRNA Manufacturing; Part 2: Enzyme Development for Oligonucleotide Therapeutics Manufacturing Using engineered joining enzymes to assemble siRNA from short building blocks, and what scaling that approach taught two companies. |
Asymchem Tianjin, China | |
Contract development and manufacturing organization for small molecules, oligonucleotides and peptides, with flow chemistry and enzymatic process capabilities. | Booth Exhibiting at Booth 402 Tue, Nov 33:00pm–6:30pmWed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Tue Nov 3 12:15–12:45 Innovating Oligonucleotide Production: Enzymatic Fragment Ligation for siRNA Joining short RNA fragments with enzymes in water instead of standard solid-phase steps, for purer siRNA at lower cost and larger scale. OligonucleotidesCMC & Manufacturing Talk Thu Nov 5 07:30–08:00 Advancing TIDES with Flow Chemistry How running peptide and oligonucleotide chemistry as a continuous flowing stream tightens control, improves safety and cuts waste. CMC & Manufacturing |
Contract development and manufacturing organization for peptides, oligonucleotides, lipids and complex APIs, with integrated drug product supply. | Booth Exhibiting at Booth 602 Tue, Nov 33:00pm–6:30pmWed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Wed Nov 4 14:30–15:00 Accelerate Timeline to Start PhI: Phase Appropriate Development and Integrated Drug Product Supply Running peptide drug substance and finished-product development side by side to reach safety testing and the first human trial sooner. Chair Thu Nov 5 13:55–14:00 |
ST Pharm Seoul, South Korea | |
South Korean contract developer and manufacturer of oligonucleotide APIs, also producing phosphoramidites and offering mRNA services. | Booth Exhibiting at Booth 503 Tue, Nov 33:00pm–6:30pmWed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Tue Nov 3 12:15–12:45 Engineered Cysteine AOC Process Development: DAR-Guided Fraction Pooling, DAR Blend-Validated Orthogonal Methods, and Conjugation Site Determination Ways to purify and measure antibody–oligonucleotide conjugates made on engineered cysteines, pooling fractions by how many oligonucleotides each antibody carries. OligonucleotidesCMC & Manufacturing |
Supplies HPLC and BioLC columns, preparative chromatography media and process systems, including continuous chromatography, for oligonucleotide and peptide purification. | Booth Exhibiting at Booth 414 Tue, Nov 33:00pm–6:30pmWed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Tue Nov 3 11:30–12:00 Innovations in Preparative Purification of Synthetic Peptides How better column materials and automation have made large-scale peptide purification cheaper, easing supply of GLP-1 drugs and insulin. |
Supplies nucleosides, phosphoramidites and other raw materials for oligonucleotide and mRNA manufacturing, plus chemoenzymatic siRNA manufacturing. | Booth Exhibiting at Booth 621 Tue, Nov 33:00pm–6:30pmWed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Tue Nov 3 11:15–11:30 Talk Thu Nov 5 13:25–13:55 Scalable Chemoenzymatic Ligation Approaches for Complex Oligonucleotides How engineered enzymes can stitch short chemical pieces into long RNA, making gene-editing guide RNA and silencing RNA purer and cheaper. OligonucleotidesCMC & Manufacturing |
Ajinomoto Bio-Pharma Services San Diego, CA | |
Contract development and manufacturing organization for oligonucleotides, peptides and biologics, offering AJIPHASE liquid-phase synthesis technology. | Booth Exhibiting at Booth 711 Tue, Nov 33:00pm–6:30pmWed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Wed Nov 4 13:25–13:55 Addressing the Next Scale of Oligonucleotide Manufacturing: CMC Guided Transition from Solid Phase Synthesis to AJIPHASE® and Chemical Enzymatic siRNA Production Why one maker plans to move oligonucleotide production from solid-phase to liquid-phase chemistry, and how enzymes could join fragments at larger scale. OligonucleotidesCMC & Manufacturing |
Supplies purification and fluid management technologies and pathogen safety testing services for manufacturers of biotherapeutics and pharmaceuticals. | Booth Exhibiting at Booth 603 Tue, Nov 33:00pm–6:30pmWed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Wed Nov 4 13:25–13:55 OCELOT®: The Open, Unified Software Platform for Modern Oligo Manufacturing How one control software runs the machines used to make and purify oligonucleotides, shown with data from real production runs. OligonucleotidesCMC & Manufacturing |
Spatial biology tools built on RNAscope in situ hybridization and the COMET system: reagents, instruments and software for RNA and protein detection. | Booth Exhibiting at Booth K8 Tue, Nov 33:00pm–6:30pmWed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Wed Nov 4 12:50–13:10 Spatially Resolving RNA Therapeutics in Heterogenous Organs: RNAscope to Correlate Biodistribution and Efficacy at Single-Cell Resolution How a tissue staining method shows which individual cells take up an RNA drug and whether it changes gene activity there. OligonucleotidesDiscovery & Clinical |
BioSpring Frankfurt, Germany | |
Contract development and manufacturing organization for oligonucleotides, from research quantities to commercial GMP supply. | Booth Exhibiting at Booth 511 Tue, Nov 33:00pm–6:30pmWed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Tue Nov 3 11:00–11:15 |
Bruker Billerica, MA | |
Makes mass spectrometry, NMR and other analytical instruments used to characterize peptides, oligonucleotides and other drug molecules. | Booth Exhibiting at Booth 308 Tue, Nov 33:00pm–6:30pmWed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Thu Nov 5 11:50–12:20 Peptide Diversity and Therapeutics by NMR: Scalable Methods from Early Sequences to Drug Candidates How nuclear magnetic resonance can check peptide structure at scale, from short test peptides to a cancer drug candidate. PeptidesCMC & Manufacturing |
Catalent Somerset, NJ | |
Contract development and manufacturing organization for drug products, including oral delivery technologies and injectable formulation and fill-finish. | Booth Exhibiting (no floor booth listed) Tue, Nov 33:00pm–6:30pmWed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Wed Nov 4 12:30–12:50 Advancing Beyond Injections: Technologies Driving Oral Delivery of Peptides Ways to get peptide drugs absorbed when swallowed rather than injected, using fatty carriers, slow-release capsules and the lining of the mouth. PeptidesDiscovery & Clinical |
Supplies pharmaceutical excipients, lipids for nucleic acid delivery, adjuvants and other ingredients for drug formulation and manufacturing. | Booth Exhibiting (no floor booth listed) Tue, Nov 33:00pm–6:30pmWed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Tue Nov 3 10:05–10:35 Optimising GAP Peptide Synthesis for Tirzepatide Fragments How anchoring a growing peptide in a chosen solvent improved the yield and purity of fragments for a GLP-1 drug. |
Cytiva Marlborough, MA | |
Supplies tools and technologies for developing, manufacturing and delivering therapeutics. | Booth Exhibiting at Booth 517 Tue, Nov 33:00pm–6:30pmWed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Wed Nov 4 11:50–12:20 An Engineer’s View: Process Intensification for Sustainability An engineer's view of how changing equipment and process steps could make solid-phase oligonucleotide synthesis more productive and less polluting. OligonucleotidesCMC & Manufacturing |
DuPont Wilmington, DE | |
Supplies purification media, including polymeric reverse-phase chromatography resins, used to purify peptides and oligonucleotides. | Booth Exhibiting at Booth 610 Tue, Nov 33:00pm–6:30pmWed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Thu Nov 5 11:50–12:20 GLP-1 Receptor Agonist Purification Combining Polymeric and Silica Reverse Phase Media How purifying the GLP-1 drug liraglutide on two different column materials, alternating acidic and basic conditions, raised both purity and yield. PeptidesCMC & Manufacturing |
Makes spray dryers and other process equipment for drying and stabilizing pharmaceutical materials. | Booth Exhibiting at Booth 523 Tue, Nov 33:00pm–6:30pmWed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Thu Nov 5 13:25–13:55 Continuous Downstream Process to Stabilize Oligonucleotides How a drying step keeps oligonucleotides stable in a continuous production line that must cope with water and other solvents. OligonucleotidesCMC & Manufacturing |
Nitto Avecia Milford, Massachusetts | |
Contract developer and manufacturer of oligonucleotide APIs, from process development through commercial GMP production. | Booth Exhibiting at Booth 413 Tue, Nov 33:00pm–6:30pmWed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Wed Nov 4 16:15–16:45 On-Resin Chemical Ligation for Next-generation siRNA Manufacturing A chemical way to join siRNA strand pieces while they are still on the solid support, developed alongside enzyme-based joining. |
OmniAb Emeryville, California | |
Licenses antibody discovery platforms built on transgenic animals to drug developers. | Booth Exhibiting at Booth K9 Tue, Nov 33:00pm–6:30pmWed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Wed Nov 4 09:55–10:05 OmniUltra™: A Dual Modality In Vivo Discovery Platform for Novel Human Antibodies and Structured Peptides How antibodies carrying unusually long loops can reach deep pockets on a target, and how those loops work alone as small peptides. PeptidesDiscovery & Clinical |
SCIEX Framingham, Massachusetts | |
Makes mass spectrometry and capillary electrophoresis systems and software for characterizing oligonucleotides and other biomolecules. | Booth Exhibiting at Booth 109 Tue, Nov 33:00pm–6:30pmWed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Tue Nov 3 12:15–12:45 From Purity to Structural Insight: Advanced CE and LC-MS Solutions for Oligonucleotide Characterization New capillary electrophoresis and mass spectrometry methods that separate oligonucleotides differing by one base and spot rare impurities. OligonucleotidesCMC & Manufacturing |
Thermo Fisher Scientific Waltham, Massachusetts | |
Supplies phosphoramidites and other oligonucleotide and RNA building blocks, purification and analytical products, and contract manufacturing services. | Booth Exhibiting at Booth 907 Tue, Nov 33:00pm–6:30pmWed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Wed Nov 4 15:40–15:50 From Building Blocks to Therapeutics: Thermo Fisher’s Integrated RNA & Oligonucleotide Supply Chain The raw materials, chemical building blocks, enzymes and early-stage production one supplier offers for RNA and oligonucleotide medicines. OligonucleotidesCMC & Manufacturing |
Supplies chromatography resins and columns, including TOYOPEARL and TSKgel, for purifying and analysing oligonucleotides, peptides and other biomolecules. | Booth Exhibiting (no floor booth listed) Tue, Nov 33:00pm–6:30pmWed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Thu Nov 5 11:50–12:20 From Purification to Characterization: Chromatographic Approaches for Nucleic Acid-based Therapeutic Modalities How the same chromatography toolbox can both purify nucleic acid medicines and measure what is actually in them during development. OligonucleotidesCMC & Manufacturing |
WuXi TIDES Shanghai, China | |
WuXi AppTec's integrated contract development and manufacturing platform for oligonucleotides, peptides and related conjugates. | Booth Exhibiting at Booth 704 Tue, Nov 33:00pm–6:30pmWed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Wed Nov 4 07:30–08:00 Overcoming Scale-Up Barriers: Ensuring Robust CMC for Next-Gen Peptide and Oligonucleotide Drugs Which manufacturing and quality choices decide whether a complex looped or chemically linked peptide drug can still be made at full scale. CMC & Manufacturing |
ADS Biotec Omaha, NE | |
Makes HPLC purification columns, buffers and WAVE systems for nucleic acid separation, including RNASep columns for mRNA purification. | Booth Exhibiting at Booth 819 Tue, Nov 33:00pm–6:30pmWed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm |
Belgian analytical contract service provider supporting development of small molecules, biologics, biosimilars and cell and gene therapies. | Booth Exhibiting at Booth 117 Tue, Nov 33:00pm–6:30pmWed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm |
Chinese pharmaceutical company producing active pharmaceutical ingredients and offering contract development and manufacturing services. | Booth Exhibiting at Booth 909 Tue, Nov 33:00pm–6:30pmWed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm |
Find buyers from TIDES Europe 2026 exhibitors
Tell us what you sell and we’ll find the people at these exhibitors most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Browse TIDES Europe 2026 by
Organization type
Focus
Exhibit hall
- Exhibitors 99
Everyone
Not affiliated with or endorsed by TIDES Europe or its organizers. Submit a correction